Dr Melvin Chin (Medical Oncologist)
- Name
- Dr Melvin Teck Meng Chin
- Qualifications
- BSc(Med) MBBS UNSW 1996
- MHM UNSW 2010
- FRACP 2007
- AFCHSM 2018
- Occupation
- Medical Oncologist
- Scientist - Researcher - Academia
- Gender
- Male
- Languages Spoken
- Cantonese
- Malay
- Medical Specialties
- Medical Oncology
- Hospital Affiliations
- Prince of Wales Hospital
- Affiliated Organisations
- Medical Oncology Group of Australia (MOGA)
- Clinical Oncological Society of Australia (COSA)
- Thoracic Oncology Group Australia (TOGA)
- American Society of Clinical Oncology (ASCO)
- European Society of Medical Oncology (ESMO)
- International Association for the Study of Lung Cancer (IASLC)
- Affiliated Universities
- University of New South Wales
- Medical Conditions
- Lung cancer
- Melanoma
- Gastrointestinal cancer
- Topics
- Cancer
- Clinical Trials
Social Media
|
|
https://www.linkedin.com/in/melvin-chin-a5669959 |
|---|
Publications
- Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: a case report http://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-016-2189-x
- Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer http://link.springer.com/article/10.1007/s40487-016-0020-4
- The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study http://theoncologist.alphamedpress.org/content/21/5/618.short
- Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: a study protocol https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-016-1331-8
- TOPS: A randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue. http://hwmaint.meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/9571
